Search For:

  • Use commas to separate words/phrases
    e.g.: gold drill equipment, drilling equipment

Search In:

Search Sectors:

View this profile in: Français
Company:
Generex Biotechnology Corp.
Website:
Location:
  • 604-555 Richmond St W
  • TORONTO, ON
  • M5V3B1
  • PO Box 200
  • TORONTO, ON
  • M5V3B1

Contact Information

Telephone:
416-364-2551
Alternate Telephone:
800-391-6755
Fax:
647-547-7104
Email:
info@generex.com
Markets:
Argentina, Australia, Brazil, Canada, France, Germany, Israel, Korea, Democratic People's Republic of, United Kingdom, United States
Number of Employees:
11-100
Year Established:
1994-09-01
Industries Classification:
325410  Pharmaceutical and Medicine Manufacturing
Total Sales ($CDN):
$200,000 to $499,999
Updated on:
2015-01-27,  Industry Canada
You must have a valid Industry Canada username and password to modify your company information.
Update Profile
Generex Biotechnology Corp.

Company Profile

Generex Pharmaceuticals Inc., is an emerging Pharmaceutical and Bio-technology company to serve global markets from its base in Toronto. The company is committed to providing high quality pharmaceuticals and to make a significant improvement in patient care. It currently has an Oral Insulin spray and a cancer vaccine in development. BIO-TECHNOLOGY represents our major business area. Generex has developed and patented 3 novel drug delivery systems technologies designed to administer proteins and peptides orally. Currently these products can only be administered by injection. The first application is insulin, where we are proving at the present time that our orally administered insulin formulation provides results similar to those achieved by injection. The benefits of Generex`s oral insulin to diabetics are enormous, both from a therapy stand point and from a quality of life (no more needles) perspective. Generex is also exploring other applications for its proprietary technologies. As a result it will test and prove the appropriate applications, and will then identify local licensees to market them on our behalf. We may also look for different technologies and products to evaluate and acquire for North American markets and/or globally.

Products/Services

  • Generex Oral-lyn Generex has developed and patented 3 novel drug delivery systems technologies designed to administer proteins and peptides orally. Currently these products can only be administered by injection. The first application is insulin, where we are proving at the present time that our orally administered insulin formulation provides results similar to those achieved by injection. The benefits of Generex`s oral insulin to diabetics are enormous, both from a therapy stand point and from a quality of life (no more needles) perspective. We also have an exciting cancer vaccine in development aimed at breast and prostate.

  • AE37 Cancer vaccine AE37 is a peptide based cancer vaccine aimed at preventing the recurrence of breast or prostate cancer.

Back to Top